Medical Devices Startups

Athaca provides AI-driven solutions for clinical trial management, including synthetic patient cohort generation for rare diseases, intelligent data quality analysis, and protocol design risk assessment. The platform operates in regulated healthcare environments with emphasis on data privacy, auditability, and compliance.

1 investor

Athos Medical Technology is a healthcare-focused company founded within the NHS England Clinical Entrepreneur Programme that develops technology to improve patient care and the efficiency of the health system. It is developing medical/pharmaceutical technology with contributions in areas such as drug delivery materials.

1 investor

Atia Vision develops OmniVu, a modular shape-changing dual-optic intraocular lens (IOL) that uses the eye's natural accommodative mechanism to restore near, intermediate, and distance vision for cataract patients. The device is investigational and not yet available for sale.

1 investor

Atlas Clinical operates as a clinical research site conducting FDA-regulated trials for pharmaceutical and biotechnology sponsors. The company recruits and manages volunteer participants through multi-phase in-human testing of new drug candidates and therapeutic devices.

1 investor

Atlas5D develops motion-sensing technology to monitor health and wellbeing for elderly adults, assisted living facilities, and clinical trial participants. The system tracks movement patterns and behavioral changes to enable early intervention and support informed healthcare decisions.

1 investor

Atlas Endoscopy develops a robotic colonoscopy system for clinical use in diagnostic and therapeutic procedures. The company targets healthcare systems and endoscopists seeking to improve patient outcomes and increase procedural capacity.

1 investor

Atlas HP develops and manages ambulatory surgical center (ASC) networks for nonprofit health systems and physicians through joint venture partnerships. The company provides strategy, operations, and infrastructure to help health systems scale surgical capacity and create revenue diversification.

1 investor

Atmo Biosciences develops an FDA-cleared ingestible capsule using gas-sensing technology to diagnose gastrointestinal dysmotility conditions for gastroenterologists. The product provides objective clinical data to help manage treatment decisions and side effects in patients, particularly those experiencing gastrointestinal complications from GLP-1 weight loss medications.

1 investor

AtomVie is a contract development and manufacturing organization (CDMO) that provides cGMP manufacturing and global distribution of radiopharmaceuticals for diagnostic and therapeutic applications. The company serves clinical developers and commercial manufacturers advancing drugs through development toward commercialization.

1 investor

ATP develops and manufactures client-specific, solvent-free and water-based adhesive tapes and films, and also provides end-to-end medical device manufacturing. It serves industries including automotive and transport, construction, medical and healthcare, graphics, electronics, optics, and appliances through a worldwide distribution network.

1 investor

Atransen Pharma is a biotech company developing novel cancer treatments through LAT1 inhibitors and transporter-based drug discovery approaches. The company's research builds on amino acid transporter science from Osaka University and aims to create more effective cancer therapies with fewer side effects.

1 investor

Atria Health and Research Institute provides personalized preventive medicine and longevity services, combining clinical care with research to demonstrate and advance disease prevention strategies. The institute serves individuals and health professionals seeking to prevent chronic disease and enhance healthy lifespan through precision-based approaches across medical specialties.

1 investor

AtriCure develops medical devices for treating atrial fibrillation and related cardiac conditions, serving electrophysiologists, cardiothoracic surgeons, and thoracic surgeons globally. The company offers ablation systems, left atrial appendage exclusion devices, minimally invasive therapies, and cryoprobes for nerve ablation and pain management in cardiac procedures.

1 investor

Atrility develops cardiac medical devices, including the AtriAmp for post-operative arrhythmia monitoring, aimed at improving care for cardiac patients. The company combines healthcare, business, and engineering expertise to bring medical technology to market.

1 investor

ATRO Medical is a Dutch clinical-stage orthopedic company developing the Artimis artificial meniscus implant (prosthesis) for patients with chronic knee pain after meniscectomy. Its device is being evaluated in clinical trials at Dutch hospitals and has received FDA breakthrough device designation.

1 investor

Atrys Health is a medical company specializing in oncology, telediagnosis, pathological anatomy, and nuclear medicine. It operates in the healthcare and diagnostics sector.

1 investor

Atsena Therapeutics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases that cause vision loss. The company focuses on genetic medicines for conditions with limited approved therapies, utilizing proprietary AAV technology platforms.

1 investor

Attomarker develops a multiplexed blood testing platform that measures multiple biomarkers simultaneously and quantitatively, using gold particle nanotechnology, microfluidics and data analytics. Its tests, including a COVID Antibody Spectrum Test that classifies Long COVID immune endotypes, serve patients, clinicians, researchers and clinical partners for precision diagnostics and personalised medicine.

1 investor

Attune Health combines genomics, proteomics, and metabolomics with functional nutrition and lifestyle modification to treat people with autoimmune and inflammatory diseases. The company leverages precision science and technology to improve patient outcomes in this healthcare sector.

1 investor

Auctus Surgical develops medical device technology to treat children's scoliosis, a pediatric spinal deformity. The company operates in the pediatric orthopedic and spinal surgery medical device space.

1 investor

Audaxis Medical develops biocompatible pelvic health implants using next-generation biomaterials designed to integrate with the body and replace legacy materials. The company focuses on women's pelvic health solutions that prioritize safety, durability, and clinical efficacy.

1 investor

AudioFocus develops hearing aids that use machine learning and microphone array technology to isolate nearby speech while filtering distant sounds, allowing users to hear conversations in noisy environments like restaurants and social gatherings.

1 investor

Auditdata provides management software for executives running multi-location audiology networks, centralizing clinical, operational, and financial data into dashboards and standardizing workflows across clinics. The platform helps hearing care providers scale operations, improve reimbursement accuracy, and maintain compliance standards across their networks.

1 investor

Aufero Medical develops TruContact, an add-on accessory device that provides on-demand catheter stability during atrial fibrillation ablation procedures. The device aims to improve consistency of ablation lesions in the moving heart, addressing AF recurrence and repeat procedures.

1 investor